InfuSystems Holdings Forecasts 6%–8% Pro-Forma Revenue Growth for 2026 Despite $7.1M Contract Impact
InfuSystem is providing annual net revenue guidance for the full year 2026 in two parts by providing the impact of the biomedical services contract restructuring, which will reduce our net revenues by $7.1 million, or